To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene AKR1A1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
600 representative clones for gene AKR1A1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BQ052730 blood, natural killer cells, cell line .a -9 to 912 1 to 932   tiling clone,   932/1025
(90 %)
33 diff
(96.8 %id)
AA491307 germinal center B cell .a 63 to 563 1 to 500   tiling clone,   500/538
(92 %)
28 diff
(94.8 %id)
AA505107 germinal center B cell .a 845 to 1279 453 to 20   tiling clone, AAA   434/434
(100 %)
2 diff
(99.6 %id)
TI_57216199   .b 1 to 843 44 to 896   tiling clone,   857/935
(91 %)
20 diff
(97.9 %id)
DA285133 corpus callosum .b 23 to 566 2 to 548   capped   547/548
(99 %)
6 diff
(99.0 %id)
DA589014 lung .b 24 to 604 2 to 584   capped   583/583
(100 %)
4 diff
(99.4 %id)
CT004403 T-Lymphocytes .b 29 to 930 1 to 904   tiling clone,   904/907
(99 %)
4 diff
(99.6 %id)
BI916205 brain .b 32 to 843 1 to 812       812/823
(98 %)
3 diff
(99.7 %id)
CR980894 T-Lymphocytes .b 34 to 873 1 to 841       841/848
(99 %)
4 diff
(99.6 %id)
BI756060 brain .b 37 to 857 1 to 827       825/827
(99 %)
8 diff
(99.1 %id)
CV808677 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 37 to 734 1 to 700       700/703
(99 %)
9 diff
(98.8 %id)
TI_57216344   .b 37 to 857 34 to 860       821/860
(95 %)
14 diff
(98.4 %id)
BG820864 anaplastic oligodendroglioma with 1p/19qloss, brain .b 39 to 705 1 to 669       669/838
(79 %)
13 diff
(98.5 %id)
BF184238 bone marrow, from chronic myelogenous leukemia .b 40 to 646 1 to 603       599/635
(94 %)
13 diff
(98.0 %id)
BG256768 embryonal carcinoma, cell line, testis .b 40 to 810 1 to 764       766/960
(79 %)
38 diff
(96.1 %id)
CB120704 Liver .b 42 to 404 1 to 363       363/363
(100 %)
1 diff
(99.8 %id)
BG748055 eye, normal pigmented retinal epithelium .b 44 to 914 1 to 874       874/880
(99 %)
14 diff
(98.5 %id)
BM906381 ovary (pool of 3) .b 52 to 843 13 to 804       788/1080
(72 %)
15 diff
(98.7 %id)
BG519607 brain, neuroblastoma .b 53 to 923 1 to 885       885/887
(99 %)
34 diff
(96.2 %id)
BI194991 brain, neuroblastoma .b 53 to 686 1 to 623       623/624
(99 %)
13 diff
(98.0 %id)
BG743377 skin .b 54 to 933 1 to 884       882/886
(99 %)
30 diff
(96.7 %id)
BM477932 lymph, lymphoma, cell line .b 54 to 838 1 to 792       792/965
(82 %)
18 diff
(98.2 %id)
CX871953 embryonic stem .b 54 to 780 1 to 727       727/727
(100 %)
2 diff
(99.8 %id)
BQ049933 lymph, lymphoma, cell line .b 55 to 957 1 to 911       911/1043
(87 %)
21 diff
(98.0 %id)
BM887841 eye .b 57 to 563 1 to 507       507/507
(100 %)
0 diff
(100 %id)
CD689893 normal nasopharynx .b 58 to 616 36 to 595       556/595
(93 %)
9 diff
(98.5 %id)
BQ059447 lymph, lymphoma, cell line .b 58 to 1026 1 to 978       978/1050
(93 %)
12 diff
(98.9 %id)
CR997352 T-Lymphocytes .b 61 to 747 1 to 687       687/688
(99 %)
1 diff
(99.9 %id)
BG031374 breast, mammary adenocarcinoma, cell line .b 62 to 810 1 to 739       739/920
(80 %)
19 diff
(98.0 %id)
AU142853   .b 62 to 804 2 to 752   capped   751/848
(88 %)
11 diff
(98.8 %id)
BM019003 astrocytoma grade IV, cell line, brain .b 65 to 863 1 to 793       793/796
(99 %)
10 diff
(98.8 %id)
TI_59389681   .b 66 to 863 123 to 914       792/795
(99 %)
9 diff
(98.9 %id)
BM560665 astrocytoma grade IV, cell line, brain .b 67 to 951 1 to 893       893/1078
(82 %)
10 diff
(99.1 %id)
BG106806 lymph, lymphoma, cell line .b 71 to 816 1 to 742       742/970
(76 %)
18 diff
(98.2 %id)
BG391510 embryonal carcinoma, cell line, testis .b 71 to 843 1 to 770       770/931
(82 %)
18 diff
(98.1 %id)
BM507311 insulinoma, Pancreas .b 72 to 641 1 to 574       570/574
(99 %)
7 diff
(98.8 %id)
BQ630911 insulinoma, Pancreas .b 72 to 667 1 to 601       597/601
(99 %)
8 diff
(98.7 %id)
CN396206 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 74 to 691 1 to 618       618/618
(100 %)
2 diff
(99.7 %id)
BE312380 brain, neuroblastoma .b 74 to 836 1 to 760       760/866
(87 %)
22 diff
(97.5 %id)
BM018201 astrocytoma grade IV, cell line, brain .b 76 to 509 1 to 434       434/436
(99 %)
7 diff
(98.4 %id)
BM452925 melanotic melanoma, skin .b 77 to 942 1 to 873       873/906
(96 %)
9 diff
(99.1 %id)
TI_59388785   .b 77 to 509 101 to 533       433/435
(99 %)
6 diff
(98.7 %id)
BQ582162 insulinoma, Pancreas .b 866 to 1324 459 to 1   tiling clone,   459/459
(100 %)
0 diff
(100 %id)
DA871469 Prostate .c 1 to 534 2 to 535   tiling clone, capped   534/534
(100 %)
2 diff
(99.7 %id)
BQ421095 embryonal carcinoma, cell line, testis .c 5 to 866 1 to 864       862/864
(99 %)
10 diff
(98.9 %id)
NM_006066.2   .c 20 to 1553 1 to 1534 exact RefSeq, AAA   1534/1534
(100 %)
0 diff
(100 %id)
BM925015 pooled lung and spleen .c 29 to 962 18 to 960       941/1077
(87 %)
32 diff
(97.1 %id)
CD671277 eye, Iris .c 30 to 689 1 to 660       660/660
(100 %)
0 diff
(100 %id)
DA974138 synovial membrane tissue from rheumatioidarthritis .c 32 to 600 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
DA508550 brain .c 36 to 611 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
BG392719 embryonal carcinoma, cell line, testis .c 39 to 736 1 to 695       695/695
(100 %)
4 diff
(99.5 %id)
BU150361 brain, neuroblastoma, cell line .c 45 to 964 1 to 920       920/921
(99 %)
12 diff
(98.7 %id)
BC000670 Colon, adenocarcinoma .c 48 to 1553 1 to 1506 exact tiling clone, available from MGC, AAA   1506/1506
(100 %)
2 diff
(99.9 %id)
DA984579 synovial membrane tissue from rheumatioidarthritis .c 55 to 371 2 to 318   capped   317/319
(99 %)
2 diff
(99.4 %id)
CR598490 Neuroblastoma Cot 25-normalized .c 58 to 1532 1 to 1475 exact     1475/1475
(100 %)
0 diff
(100 %id)
CR616743 HeLa cells Cot 25-normalized .c 58 to 1556 1 to 1499 exact tiling clone,   1499/1499
(100 %)
0 diff
(100 %id)
AL523181 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 58 to 870 1 to 814   fully sequenced,   814/814
(100 %)
12 diff
(98.6 %id)
AL555848 placenta .c 59 to 1080 1 to 1021       1021/1021
(100 %)
7 diff
(99.4 %id)
CR617059 Neuroblastoma Cot 25-normalized .c 60 to 1549 1 to 1490 exact     1490/1490
(100 %)
0 diff
(100 %id)
BX393931 Neuroblastoma Cot 25-normalized .c 60 to 977 1 to 918   fully sequenced,   918/918
(100 %)
5 diff
(99.5 %id)
BF306886 muscle, rhabdomyosarcoma .c 65 to 836 1 to 757       757/837
(90 %)
22 diff
(97.4 %id)
BE304571 adenocarcinoma cell line, colon .c 68 to 641 1 to 582       582/582
(100 %)
11 diff
(98.2 %id)
CR613190 Neuroblastoma Cot 25-normalized .c 77 to 1518 1 to 1442 exact     1442/1442
(100 %)
0 diff
(100 %id)
AL528453 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 77 to 718 1 to 642   fully sequenced,   642/642
(100 %)
1 diff
(99.9 %id)
CR605893 Neuroblastoma Cot 10-normalized .c 83 to 1530 1 to 1448 exact     1448/1448
(100 %)
0 diff
(100 %id)
AL519863 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .c 83 to 870 1 to 788   fully sequenced,   788/788
(100 %)
0 diff
(100 %id)
BF382329 brain, primitive neuroectoderm .c 90 to 823 1 to 750       630/771
(81 %)
36 diff
(95.4 %id)
DA843878 placenta .c 92 to 647 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
BG746862 adenocarcinoma cell line, colon .c 101 to 875 1 to 772       772/772
(100 %)
9 diff
(98.9 %id)
CR600290 Neuroblastoma Cot 50-normalized .c 109 to 1534 1 to 1426 exact     1426/1426
(100 %)
0 diff
(100 %id)
AL528609 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .c 109 to 870 1 to 763   fully sequenced,   656/656
(100 %)
39 diff
(94.1 %id)
BE745750 adenocarcinoma cell line, ovary .c 112 to 887 1 to 773       773/980
(78 %)
11 diff
(98.9 %id)
CN271968 embryonic stem cells, DMSO-treated H9 cellline .c 114 to 552 1 to 439       439/439
(100 %)
4 diff
(99.1 %id)
BF307890 muscle, rhabdomyosarcoma .c 116 to 757 1 to 639       639/949
(67 %)
8 diff
(99.2 %id)
BE298862 muscle, rhabdomyosarcoma .c 136 to 763 1 to 628       628/630
(99 %)
6 diff
(99.1 %id)
TI_57241456   .c 199 to 1048 28 to 878       851/880
(96 %)
17 diff
(98.1 %id)
BI913562 brain .c 205 to 1048 1 to 845       845/847
(99 %)
11 diff
(98.8 %id)
BM546313 ovary (pool of 3) .c 268 to 1230 12 to 982   AAA   971/1098
(88 %)
31 diff
(97.2 %id)
CA941949 Pancreas, Purified pancreatic islet .c 277 to 894 1 to 618       618/618
(100 %)
0 diff
(100 %id)
CA772783 Pancreas, Purified pancreatic islet .c 285 to 1066 1 to 782   fully sequenced,   782/782
(100 %)
3 diff
(99.7 %id)
BG743374 skin .c 302 to 1149 1 to 846       846/846
(100 %)
9 diff
(99.0 %id)
BE890374 melanotic melanoma, skin .c 320 to 1083 1 to 768       768/793
(96 %)
22 diff
(97.3 %id)
BM904854 melanotic melanoma, skin .c 328 to 1195 12 to 897       884/1013
(87 %)
30 diff
(97.1 %id)
CD621751   .c 402 to 1162 766 to 4       761/770
(98 %)
8 diff
(99.0 %id)
BI258033 cervical carcinoma cell line, cervix .c 409 to 1192 1 to 780       780/976
(79 %)
23 diff
(97.7 %id)
CD621753   .c 419 to 1162 749 to 4       746/753
(99 %)
6 diff
(99.3 %id)
CD621754   .c 419 to 1055 142 to 782       641/647
(99 %)
14 diff
(97.9 %id)
J04794   .c 424 to 1555 1 to 1132 exact     1132/1132
(100 %)
1 diff
(100.0 %id)
BE799397 lung, small cell carcinoma .c 425 to 1110 12 to 697       686/697
(98 %)
8 diff
(98.9 %id)
DN998344 bone marrow .c 455 to 1216 1 to 763       763/765
(99 %)
11 diff
(98.6 %id)
BG398979 Kidney .c 471 to 1216 1 to 744       744/837
(88 %)
12 diff
(98.6 %id)
BM705233 eye, RPE and Choroid .c 655 to 1160 1 to 506   fully sequenced,   506/506
(100 %)
0 diff
(100 %id)
AL528424 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 657 to 1518 862 to 1   fully sequenced,   862/862
(100 %)
2 diff
(99.8 %id)
AA504968   .c 661 to 1066 1 to 400   fully sequenced,   400/400
(100 %)
2 diff
(99.5 %id)
TI_1948076028   .c 709 to 1460 878 to 124       755/1118
(67 %)
38 diff
(96.7 %id)
TI_1948075473   .c 728 to 1460 864 to 124       741/1491
(49 %)
20 diff
(98.7 %id)
AI375876 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 756 to 1553 816 to 22   AAA   795/831
(95 %)
16 diff
(98.1 %id)
CN396191 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 780 to 1449 9 to 680       672/680
(98 %)
8 diff
(98.9 %id)
BG760691 melanotic melanoma, high MDR (cell line), skin .c 792 to 1554 1 to 765       765/786
(97 %)
11 diff
(98.7 %id)
BG764414 melanotic melanoma, high MDR (cell line), skin .c 792 to 1552 1 to 756   AAA   756/756
(100 %)
5 diff
(99.4 %id)
BG763886 melanotic melanoma, high MDR (cell line), skin .c 792 to 1554 1 to 768       768/828
(92 %)
14 diff
(98.4 %id)
AL519862 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .c 809 to 1530 721 to 1   fully sequenced,   721/721
(100 %)
3 diff
(99.6 %id)
AL523180 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 809 to 1532 725 to 1   fully sequenced,   725/725
(100 %)
17 diff
(97.7 %id)
AL563203 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .c 809 to 1485 727 to 51   fully sequenced,   677/681
(99 %)
6 diff
(99.2 %id)
BQ315748 colon .c 835 to 1449 644 to 32       613/735
(83 %)
32 diff
(95.7 %id)
TI_149312780   .c 839 to 1553 812 to 99   AAA   714/957
(74 %)
26 diff
(97.3 %id)
BX373674 Placenta Cot 25-normalized .c 840 to 1549 714 to 1       714/943
(75 %)
10 diff
(99.0 %id)
TI_1948075755   .c 840 to 1460 746 to 125       622/1160
(53 %)
12 diff
(99.0 %id)
TI_151750087   .c 840 to 1555 821 to 101   AAA   721/1208
(59 %)
14 diff
(98.9 %id)
BU179826 melanotic melanoma, cell line, skin .c 841 to 1553 25 to 734   AAA   710/734
(96 %)
6 diff
(99.2 %id)
TI_149287058   .c 843 to 1552 801 to 93   AAA   709/1102
(64 %)
3 diff
(99.8 %id)
BU839028 melanotic melanoma, cell line, skin .c 844 to 1553 1 to 709   AAA   709/709
(100 %)
1 diff
(99.9 %id)
TI_149298324   .c 844 to 1552 829 to 123   AAA   707/896
(78 %)
8 diff
(99.2 %id)
BU858339 mixed (pool of 40 RNAs) .c 845 to 1554 1 to 714       714/797
(89 %)
8 diff
(99.0 %id)
BM976696 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 846 to 1552 725 to 19   AAA   707/707
(100 %)
0 diff
(100 %id)
BQ181727 Knee, Osteoarthritic Cartilage .c 847 to 1552 724 to 19   AAA   706/706
(100 %)
0 diff
(100 %id)
BU624455 cell lines, Enchondroma .c 847 to 1553 725 to 19   AAA   707/707
(100 %)
0 diff
(100 %id)
AI962881 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 851 to 1553 714 to 12   AAA   703/703
(100 %)
8 diff
(98.9 %id)
TI_149291766   .c 851 to 1552 762 to 62   AAA   701/702
(99 %)
1 diff
(99.9 %id)
AW005401 anaplastic oligodendroglioma, brain .c 852 to 1554 710 to 7       704/780
(90 %)
17 diff
(97.9 %id)
BQ015264 Chondrosarcoma, Left Pubic Bone .c 857 to 1553 715 to 19   AAA   697/697
(100 %)
1 diff
(99.9 %id)
BU631634 cell lines, Chondrosarcoma .c 859 to 1555 715 to 19   AAA   697/697
(100 %)
1 diff
(99.9 %id)
TI_149291147   .c 863 to 1553 768 to 78   AAA   691/691
(100 %)
1 diff
(99.9 %id)
BU682179 lung .c 871 to 1552 699 to 19   AAA   681/681
(100 %)
1 diff
(99.9 %id)
BE745658 adenocarcinoma cell line, ovary .c 873 to 1555 1 to 684   AAA   684/684
(100 %)
5 diff
(99.3 %id)
CA440163 lung, Metastatic Chondrosarcoma .c 881 to 1553 690 to 19   AAA   672/672
(100 %)
1 diff
(99.9 %id)
BM973802 lung .c 884 to 1553 688 to 19   AAA   670/670
(100 %)
1 diff
(99.9 %id)
BQ007638 Chondrosarcoma, Left Pelvis .c 887 to 1555 685 to 17   AAA   669/669
(100 %)
0 diff
(100 %id)
BQ302041 breast .c 897 to 1498 602 to 1       602/604
(99 %)
18 diff
(97.1 %id)
BQ015820 lung, Metastatic Chondrosarcoma .c 899 to 1553 673 to 19   AAA   655/655
(100 %)
0 diff
(100 %id)
AI360197 anaplastic oligodendroglioma, brain .c 901 to 1552 644 to 1       644/644
(100 %)
12 diff
(98.2 %id)
CA308814 Alveolar Macrophage, lung .c 901 to 1553 668 to 17   AAA   652/652
(100 %)
1 diff
(99.9 %id)
CA308232 Alveolar Macrophage, lung .c 901 to 1552 670 to 19   AAA   652/652
(100 %)
0 diff
(100 %id)
BM851713 stomach .c 903 to 1460 1 to 558       558/558
(100 %)
0 diff
(100 %id)
BM565572 insulinoma, Pancreas .c 904 to 1548 645 to 1       645/645
(100 %)
1 diff
(99.9 %id)
BQ436995 melanotic melanoma, skin .c 908 to 1554 1 to 647       647/845
(76 %)
1 diff
(99.9 %id)
BF440016 brain, glioblastoma (pooled) .c 913 to 1553 640 to 1       640/640
(100 %)
10 diff
(98.5 %id)
CA308978 Alveolar Macrophage, lung .c 913 to 1553 658 to 19   AAA   640/640
(100 %)
1 diff
(99.9 %id)
CA941778 Pancreas, Purified pancreatic islet .c 934 to 1552 619 to 1       619/619
(100 %)
1 diff
(99.9 %id)
CA424740 cell lines, Chondrosarcoma .c 936 to 1553 636 to 19   AAA   618/618
(100 %)
0 diff
(100 %id)
BM799541 eye, retinoblastoma .c 937 to 1552 11 to 626       616/655
(94 %)
6 diff
(99.1 %id)
AA573848 colon, tumor .c 939 to 1552 622 to 12   AAA   611/611
(100 %)
10 diff
(98.4 %id)
AW192651 adenocarcinoma, Pancreas .c 939 to 1545 608 to 1       608/608
(100 %)
8 diff
(98.7 %id)
BU955525 mixed (pool of 40 RNAs) .c 940 to 1552 1 to 613       613/621
(98 %)
4 diff
(99.4 %id)
BM982941 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 940 to 1553 632 to 19   AAA   614/614
(100 %)
0 diff
(100 %id)
BQ329140 lung_normal .c 946 to 1454 508 to 2       507/508
(99 %)
8 diff
(98.5 %id)
BX350902 Neuroblastoma Cot 25-normalized .c 947 to 1549 606 to 1   fully sequenced,   606/606
(100 %)
2 diff
(99.7 %id)
BQ028947 Bone, Subchondral Bone .c 948 to 1552 623 to 19   AAA   605/605
(100 %)
1 diff
(99.9 %id)
BG938605 Bone, Hip .c 948 to 1552 624 to 20   AAA   605/605
(100 %)
0 diff
(100 %id)
BU689276 lung .c 948 to 1552 623 to 19   AAA   605/605
(100 %)
1 diff
(99.9 %id)
BM983081 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 950 to 1552 621 to 19   AAA   603/603
(100 %)
5 diff
(99.2 %id)
BM978326 lung .c 956 to 1553 616 to 19   AAA   598/598
(100 %)
9 diff
(98.5 %id)
AA099092   .c 957 to 1552 599 to 3     Submitted on the opposite strand 599/643
(93 %)
19 diff
(97.1 %id)
BX389937   .c 960 to 1552 1 to 593       593/593
(100 %)
2 diff
(99.7 %id)
BX389938   .c 960 to 1552 1 to 592       592/596
(99 %)
4 diff
(99.4 %id)
BM665881 eye, human retina .c 962 to 1552 609 to 19   AAA   591/591
(100 %)
0 diff
(100 %id)
TI_57152659   .c 968 to 1552 28 to 612   AAA   585/612
(95 %)
6 diff
(99.1 %id)
BI764553 pooled colon, kidney, stomach .c 975 to 1552 1 to 578   AAA   578/578
(100 %)
0 diff
(100 %id)
BM972443 lung .c 977 to 1552 594 to 19   AAA   576/576
(100 %)
0 diff
(100 %id)
CA431652 Alveolar Macrophage, lung .c 977 to 1552 594 to 19   AAA   576/576
(100 %)
0 diff
(100 %id)
BQ773247 Chondrosarcoma Cell line .c 978 to 1553 594 to 19   AAA   576/576
(100 %)
0 diff
(100 %id)
AA487324 lung .c 990 to 1339 1 to 350   fully sequenced,   350/350
(100 %)
2 diff
(99.5 %id)
AW163318 brain, frontal lobe .c 991 to 1545 1 to 556   fully sequenced,   556/556
(100 %)
12 diff
(97.9 %id)
BE858186 brain, glioblastoma (pooled) .c 994 to 1553 560 to 1       560/560
(100 %)
0 diff
(100 %id)
AW951584   .c 995 to 1554 572 to 12     Submitted on the opposite strand 562/573
(98 %)
9 diff
(98.5 %id)
CA771912 Pancreas, Purified pancreatic islet .c 1005 to 1554 551 to 2   fully sequenced,   550/551
(99 %)
0 diff
(100 %id)
AA489763   .c 1007 to 1552 542 to 1   fully sequenced,   542/542
(100 %)
6 diff
(98.9 %id)
BF436733 fibrotheoma, ovary .c 1015 to 1553 556 to 18   AAA   539/539
(100 %)
0 diff
(100 %id)
AA456705 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1033 to 1339 16 to 320   fully sequenced,   305/320
(95 %)
6 diff
(98.2 %id)
AI334418 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1034 to 1555 531 to 11   AAA   521/521
(100 %)
4 diff
(99.3 %id)
CR739979   .c 1053 to 1553 517 to 15   AAA   503/503
(100 %)
2 diff
(99.7 %id)
AI190652 heart .c 1057 to 1556 501 to 2       500/501
(99 %)
2 diff
(99.7 %id)
CV359083 colon_normal .c 1061 to 1543 528 to 46     Submitted on the opposite strand 483/528
(91 %)
2 diff
(99.7 %id)
BQ027362 mixed .c 1079 to 1552 491 to 19   AAA   473/473
(100 %)
1 diff
(99.8 %id)
BP387064 pancreatic islet .c 1080 to 1552 1 to 473     Submitted on the opposite strand 473/477
(99 %)
1 diff
(99.8 %id)
AA837985 colon, colon tumor .c 1083 to 1553 467 to 1       467/471
(99 %)
5 diff
(99.0 %id)
AI298986 carcinoid, lung .c 1093 to 1556 465 to 2       464/465
(99 %)
1 diff
(99.8 %id)
AW071946 anaplastic oligodendroglioma, brain .c 1099 to 1553 455 to 1       455/455
(100 %)
0 diff
(100 %id)
AI624951 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 1101 to 1553 469 to 18   AAA   452/452
(100 %)
3 diff
(99.4 %id)
AI624969 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 1101 to 1553 469 to 18   AAA   452/452
(100 %)
1 diff
(99.8 %id)
AI361095 brain, glioblastoma (pooled) .c 1104 to 1553 450 to 1       450/450
(100 %)
0 diff
(100 %id)
AI751152 Bone, Hip .c 1111 to 1530 427 to 8       420/427
(98 %)
0 diff
(100 %id)
AI080730   .c 1114 to 1554 443 to 3       441/443
(99 %)
0 diff
(100 %id)
AI318107 adenocarcinoma, colon .c 1126 to 1553 448 to 21   AAA   428/428
(100 %)
1 diff
(99.8 %id)
BU736805 eye, RPE and Choroid .c 1130 to 1553 444 to 21   fully sequenced, AAA   424/426
(99 %)
0 diff
(100 %id)
AI150992 brain, glioblastoma (pooled) .c 1142 to 1552 411 to 1       411/411
(100 %)
0 diff
(100 %id)
AV647347 corresponding non cancerous liver tissue .c 1143 to 1555 1 to 413   AAA Submitted on the opposite strand 413/413
(100 %)
0 diff
(100 %id)
AV647386 corresponding non cancerous liver tissue .c 1143 to 1555 1 to 413   AAA Submitted on the opposite strand 413/413
(100 %)
0 diff
(100 %id)
AA834509 Kidney, kidney tumor .c 1147 to 1552 404 to 1       404/404
(100 %)
2 diff
(99.6 %id)
H30523 eye, retina .c 1148 to 1417 270 to 1       270/270
(100 %)
0 diff
(100 %id)
AA167137   .c 1156 to 1534 388 to 2     Submitted on the opposite strand 387/399
(96 %)
8 diff
(98.0 %id)
CN396187 embryonic stem cells, cell lines H1, H7, andH9 .c 1169 to 1435 267 to 1     Submitted on the opposite strand 267/267
(100 %)
1 diff
(99.7 %id)
AA617946 lung, lung tumor .c 1196 to 1552 386 to 30   AAA   357/357
(100 %)
0 diff
(100 %id)
AW157520 brain, frontal lobe .c 1205 to 1554 355 to 6   fully sequenced,   350/355
(98 %)
0 diff
(100 %id)
AA456307 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1278 to 1552 275 to 2   fully sequenced,   274/275
(99 %)
0 diff
(100 %id)
AA487171 lung .c 1278 to 1556 280 to 2   fully sequenced,   279/280
(99 %)
0 diff
(100 %id)
BQ716684 sympathetic trunk .c 1407 to 1552 1 to 146   AAA   146/146
(100 %)
1 diff
(99.4 %id)
FN061749 breast carcinoma .c 1441 to 1548 1 to 108       108/108
(100 %)
0 diff
(100 %id)
EC476222 Prostate .c 1453 to 1553 111 to 11   AAA   101/101
(100 %)
0 diff
(100 %id)
EC484039 Prostate .c 1453 to 1553 100 to 1       100/100
(100 %)
1 diff
(99.0 %id)
EC499366 Prostate .c 1453 to 1551 97 to 4       94/97
(96 %)
0 diff
(100 %id)
FN113209 breast carcinoma .c 1470 to 1552 1 to 84       84/84
(100 %)
1 diff
(98.9 %id)
BF837024 head_neck .d 1 to 263 270 to 3   tiling clone, Submitted on the opposite strand 268/272
(98 %)
0 diff
(100 %id)
BQ424937 melanotic melanoma, skin .d 177 to 858 1 to 682   tiling clone,   682/926
(73 %)
16 diff
(98.3 %id)
BI549149 brain, hippocampus .d 412 to 1257 1 to 848       848/848
(100 %)
13 diff
(98.5 %id)
TI_44166850   .d 417 to 1257 86 to 928       843/928
(90 %)
14 diff
(98.5 %id)
BI260943 cervical carcinoma cell line, cervix .d 443 to 1172 1 to 728       728/728
(100 %)
2 diff
(99.8 %id)
BM804204 eye, retinoblastoma .d 448 to 1308 1 to 867       867/1101
(78 %)
26 diff
(97.7 %id)
BG776348 lung, mucoepidermoid carcinoma .d 449 to 1190 1 to 744       744/744
(100 %)
18 diff
(97.6 %id)
BG696215 skin .d 455 to 1080 1 to 626       626/626
(100 %)
3 diff
(99.6 %id)
BI669582 brain, hypothalamus .d 455 to 1085 1 to 630       630/631
(99 %)
6 diff
(99.1 %id)
TI_44345122   .d 460 to 1085 84 to 708       625/709
(88 %)
8 diff
(98.9 %id)
NM_153326.1   .d 460 to 1865 1 to 1406 exact RefSeq, AAA   1406/1406
(100 %)
0 diff
(100 %id)
DA896396 skeletal muscle .d 461 to 1011 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DB495493 hypothalamus .d 463 to 964 1 to 503       503/503
(100 %)
1 diff
(99.9 %id)
DB497060 hypothalamus .d 463 to 944 1 to 482       482/482
(100 %)
2 diff
(99.6 %id)
DB498964 hypothalamus .d 463 to 955 1 to 493       493/493
(100 %)
0 diff
(100 %id)
DA845212 placenta .d 467 to 1043 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
CR607253 Neuroblastoma Cot 25-normalized .d 471 to 1836 1 to 1366 exact     1366/1366
(100 %)
0 diff
(100 %id)
AL525486 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 471 to 1182 1 to 711   fully sequenced,   711/711
(100 %)
0 diff
(100 %id)
CB269260 adipose .d 473 to 1100 1 to 627       627/627
(100 %)
2 diff
(99.7 %id)
DA550374   .d 476 to 1035 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DB120315 thymus .d 476 to 1012 2 to 539   capped   538/538
(100 %)
2 diff
(99.7 %id)
DA482582   .d 479 to 1045 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
BG285134 adenocarcinoma, cell line, Prostate .d 479 to 1118 1 to 640       640/640
(100 %)
3 diff
(99.6 %id)
DA690832   .d 479 to 1051 2 to 574   capped   573/573
(100 %)
3 diff
(99.5 %id)
DA904396   .d 479 to 1008 2 to 531   capped   530/530
(100 %)
3 diff
(99.5 %id)
BQ425444 eye, retinoblastoma .d 481 to 1286 9 to 825       817/882
(92 %)
27 diff
(97.0 %id)
BF309263 muscle, rhabdomyosarcoma .d 483 to 1152 1 to 668       668/905
(73 %)
11 diff
(98.8 %id)
BM809226 amelanotic melanoma, cell line, skin .d 484 to 1498 23 to 1050       1028/1069
(96 %)
32 diff
(97.1 %id)
BM423724 amelanotic melanoma, cell line, skin .d 484 to 1455 1 to 976       976/1022
(95 %)
15 diff
(98.6 %id)
BU597834 mixed (pool of 40 RNAs) .d 487 to 1294 1 to 809       809/809
(100 %)
14 diff
(98.3 %id)
DB197753 trachea .d 489 to 1073 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
BE269974 Burkitt lymphoma, lymph .d 490 to 1152 1 to 657       657/674
(97 %)
9 diff
(98.7 %id)
BG438226 large cell carcinoma, lung .d 490 to 1254 1 to 774       774/774
(100 %)
36 diff
(95.4 %id)
BE559568 Burkitt lymphoma, lymph .d 491 to 1298 1 to 799       799/984
(81 %)
28 diff
(97.2 %id)
DA956970 Spleen .d 494 to 1046 2 to 555   capped   554/554
(100 %)
3 diff
(99.5 %id)
DA642545 Liver .d 495 to 1000 2 to 507   capped   506/508
(99 %)
1 diff
(99.9 %id)
DA261145 caudate nucleus .d 496 to 1060 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA691194   .d 496 to 1065 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
BQ777074 Pancreas, Purified pancreatic islet .d 498 to 1134 1 to 637       637/637
(100 %)
0 diff
(100 %id)
BE294547 muscle, rhabdomyosarcoma .d 504 to 1148 1 to 644       644/644
(100 %)
2 diff
(99.7 %id)
BE296889 muscle, rhabdomyosarcoma .d 504 to 1015 1 to 512       512/512
(100 %)
1 diff
(99.9 %id)
BE263947 lung, small cell carcinoma .d 506 to 1148 1 to 645       645/698
(92 %)
5 diff
(99.3 %id)
AL519412 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 507 to 1336 1 to 831   fully sequenced,   831/831
(100 %)
5 diff
(99.4 %id)
CR614844 Neuroblastoma Cot 10-normalized .d 508 to 1835 1 to 1328 exact     1328/1328
(100 %)
0 diff
(100 %id)
BE266229 lung, small cell carcinoma .d 511 to 1152 1 to 638       638/682
(93 %)
6 diff
(99.2 %id)
BE871904 adenocarcinoma, colon .d 512 to 1280 1 to 753       758/926
(81 %)
37 diff
(96.1 %id)
CR621968 Neuroblastoma Cot 25-normalized .d 515 to 1707 1 to 1193       1193/1193
(100 %)
0 diff
(100 %id)
AL527312 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 515 to 1182 1 to 668   fully sequenced,   668/668
(100 %)
0 diff
(100 %id)
BQ226215 embryonal carcinoma, cell line, testis .d 518 to 1321 1 to 819       819/916
(89 %)
37 diff
(96.0 %id)
BE298073 muscle, rhabdomyosarcoma .d 519 to 1152 1 to 633       633/691
(91 %)
4 diff
(99.5 %id)
CX756807 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 519 to 1253 1 to 729     Submitted on the opposite strand 729/729
(100 %)
9 diff
(98.8 %id)
BM464131 melanotic melanoma, skin .d 524 to 1541 1 to 1022       1022/1117
(91 %)
43 diff
(96.2 %id)
CV811306 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 524 to 1251 1 to 728       728/728
(100 %)
4 diff
(99.5 %id)
BE903027 choriocarcinoma, placenta .d 525 to 1306 1 to 786       786/849
(92 %)
27 diff
(96.9 %id)
BE902603 choriocarcinoma, placenta .d 525 to 1353 1 to 840       840/1204
(69 %)
74 diff
(93.9 %id)
BQ219852 leiomyosarcoma, uterus .d 525 to 1412 1 to 900       897/989
(90 %)
22 diff
(97.8 %id)
BE900868 choriocarcinoma, placenta .d 530 to 1150 1 to 623       623/1029
(60 %)
12 diff
(98.9 %id)
CX873546 embryonic stem .d 530 to 1345 1 to 816       816/816
(100 %)
1 diff
(99.9 %id)
CB146204 Liver .d 531 to 735 1 to 205       205/205
(100 %)
2 diff
(99.1 %id)
DA693902   .d 532 to 1099 2 to 570   capped   569/569
(100 %)
3 diff
(99.5 %id)
DB286086 uterus .d 532 to 1079 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DA898156 skeletal muscle .d 533 to 1082 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
BM468782 embryonal carcinoma, cell line, testis .d 536 to 1549 1 to 1018       1018/1020
(99 %)
19 diff
(98.2 %id)
BU192698 eye, retinoblastoma .d 536 to 1396 6 to 867       862/867
(99 %)
16 diff
(98.2 %id)
BU184114 melanotic melanoma, skin .d 541 to 1237 1 to 709       709/903
(78 %)
14 diff
(98.5 %id)
BU535615 adenocarcinoma, cell line, breast .d 542 to 1354 10 to 836       827/908
(91 %)
25 diff
(97.3 %id)
BE889043 leiomyosarcoma, uterus .d 543 to 1290 1 to 748       748/907
(82 %)
23 diff
(97.5 %id)
BQ426013 melanotic melanoma, skin .d 543 to 1327 1 to 793       793/917
(86 %)
18 diff
(98.1 %id)
AA485195 germinal center B cell .d 546 to 903 7 to 363       357/363
(98 %)
6 diff
(98.4 %id)
FN076103 breast carcinoma .d 552 to 671 120 to 1     Submitted on the opposite strand 120/120
(100 %)
0 diff
(100 %id)
BM559393 amelanotic melanoma, cell line, skin .d 555 to 1446 1 to 901       901/1028
(87 %)
13 diff
(98.8 %id)
CR616472 Neuroblastoma Cot 50-normalized .d 556 to 1839 1 to 1284 exact     1284/1284
(100 %)
0 diff
(100 %id)
AL529459 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .d 556 to 1182 1 to 627   fully sequenced,   627/627
(100 %)
0 diff
(100 %id)
BG023722 duodenal adenocarcinoma, cell line, small intestine .d 557 to 1353 1 to 797       797/861
(92 %)
44 diff
(94.9 %id)
BQ058315 lymph, lymphoma, cell line .d 558 to 1540 1 to 989       989/989
(100 %)
8 diff
(99.2 %id)
BQ066220 lymph, lymphoma, cell line .d 558 to 1499 1 to 953       953/958
(99 %)
22 diff
(97.8 %id)
CN396189 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 579 to 1000 1 to 422       422/423
(99 %)
2 diff
(99.6 %id)
CR604674 Neuroblastoma Cot 10-normalized .d 600 to 1837 1 to 1238 exact     1238/1238
(100 %)
0 diff
(100 %id)
AL521637 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 600 to 1090 1 to 492   fully sequenced,   492/492
(100 %)
1 diff
(99.8 %id)
CR606043 Neuroblastoma Cot 25-normalized .d 605 to 1840 1 to 1236 exact tiling clone,   1236/1236
(100 %)
0 diff
(100 %id)
AL524834 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 605 to 1182 1 to 578   fully sequenced,   578/578
(100 %)
0 diff
(100 %id)
BG532285 embryonal carcinoma, testis .d 612 to 1321 1 to 719       719/988
(72 %)
20 diff
(98.0 %id)
BQ431942 eye, retinoblastoma .d 616 to 1505 1 to 897       897/902
(99 %)
12 diff
(98.7 %id)
BQ957616 large cell carcinoma, lung .d 651 to 1574 4 to 930       927/934
(99 %)
18 diff
(98.1 %id)
BG503083 embryonal carcinoma, testis .d 667 to 1364 1 to 697       697/697
(100 %)
3 diff
(99.6 %id)
AK293083 uterus .d 681 to 1865 1 to 1185 V305A     1185/1185
(100 %)
2 diff
(99.9 %id)
DB283256 uterus .d 682 to 1222 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
BU168523 melanotic melanoma, cell line, skin .d 690 to 1466 1 to 785       785/865
(90 %)
14 diff
(98.4 %id)
CB144805 Liver .d 691 to 1125 1 to 435       435/435
(100 %)
1 diff
(99.8 %id)
CN396205 embryonic stem cells, DMSO-treated H9 cellline .d 696 to 1447 1 to 752       752/752
(100 %)
0 diff
(100 %id)
CK005883 brain/CNS, Human Brain - Frontal Cortex .d 696 to 1361 1 to 665       665/665
(100 %)
4 diff
(99.4 %id)
BM739568 stomach .d 696 to 1212 1 to 517       517/517
(100 %)
3 diff
(99.5 %id)
BG169382 hypernephroma, cell line, Kidney .d 697 to 1530 1 to 825       825/864
(95 %)
34 diff
(96.1 %id)
CN396188 embryonic stem cells, cell lines H1, H7, andH9 .d 698 to 1058 1 to 361       361/361
(100 %)
2 diff
(99.5 %id)
CB144857 Liver .d 698 to 1196 1 to 499       499/499
(100 %)
1 diff
(99.8 %id)
BP871985 embryonal kidney .d 699 to 1301 1 to 603       603/603
(100 %)
0 diff
(100 %id)
BG398660 Kidney .d 699 to 1356 1 to 657       657/864
(76 %)
7 diff
(99.2 %id)
CB148262 Liver .d 699 to 1228 1 to 530       530/530
(100 %)
1 diff
(99.9 %id)
BQ893427 epidermoid carcinoma, cell line, salivary gland .d 700 to 1549 1 to 857       857/897
(95 %)
10 diff
(98.9 %id)
BQ668374 epidermoid carcinoma, cell line, salivary gland .d 700 to 1542 1 to 851       851/935
(91 %)
10 diff
(99.0 %id)
BC005394 Kidney, hypernephroma .d 701 to 1862 1 to 1162 exact available from MGC, AAA   1162/1164
(99 %)
2 diff
(99.9 %id)
BF683198 leiomyosarcoma cell line, uterus .d 701 to 1343 1 to 646       646/908
(71 %)
13 diff
(98.6 %id)
BQ668603 epidermoid carcinoma, cell line, salivary gland .d 705 to 1542 1 to 847       847/880
(96 %)
45 diff
(94.9 %id)
BE269956 Burkitt lymphoma, lymph .d 707 to 1345 1 to 637       637/726
(87 %)
10 diff
(98.7 %id)
BE513275 Burkitt lymphoma, lymph .d 707 to 1276 1 to 570       570/570
(100 %)
0 diff
(100 %id)
BU928506 brain, glioblastoma .d 708 to 1460 1 to 760       760/763
(99 %)
20 diff
(97.4 %id)
DR760104 embryonic stem .d 708 to 1507 1 to 800       800/800
(100 %)
0 diff
(100 %id)
BG432874 Kidney .d 709 to 1455 1 to 749       749/749
(100 %)
21 diff
(97.2 %id)
CB142290 Liver .d 709 to 1159 1 to 451       451/451
(100 %)
2 diff
(99.6 %id)
AU100339   .d 710 to 1009 1 to 300       300/300
(100 %)
0 diff
(100 %id)
CD701296 normal nasopharynx .d 710 to 1344 15 to 649       635/649
(97 %)
6 diff
(99.1 %id)
CB147862 Liver .d 710 to 1217 1 to 508       508/508
(100 %)
1 diff
(99.9 %id)
CN396201 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 714 to 1049 1 to 336       336/336
(100 %)
3 diff
(99.2 %id)
BQ057404 lymph, lymphoma, cell line .d 714 to 1545 1 to 836       836/1026
(81 %)
13 diff
(98.8 %id)
BQ057927 lymph, lymphoma, cell line .d 714 to 1716 1 to 1012       1012/1048
(96 %)
23 diff
(97.9 %id)
BQ065560 lymph, lymphoma, cell line .d 714 to 1477 1 to 766       766/1061
(72 %)
19 diff
(98.3 %id)
CN396194 embryonic stem cells, cell lines H1, H7, andH9 .d 715 to 1408 1 to 694       694/694
(100 %)
2 diff
(99.8 %id)
BG324336 Kidney, renal cell adenocarcinoma .d 715 to 1528 1 to 796       796/959
(83 %)
33 diff
(96.6 %id)
BG252244 adenocarcinoma, cell line, Liver .d 716 to 1349 1 to 636       636/956
(66 %)
3 diff
(99.7 %id)
BG824705 adenocarcinoma cell line, colon .d 716 to 1463 1 to 753       753/757
(99 %)
16 diff
(97.9 %id)
BM552210 leiomyosarcoma, uterus .d 716 to 1628 1 to 919       919/1009
(91 %)
18 diff
(98.3 %id)
BU528442 epidermoid carcinoma, cell line, lung .d 718 to 1635 1 to 919       919/921
(99 %)
9 diff
(99.1 %id)
CV571053 cornea, eye .d 719 to 1345 1 to 627       627/627
(100 %)
0 diff
(100 %id)
TI_57149317   .d 720 to 1353 24 to 657       634/657
(96 %)
6 diff
(99.1 %id)
BQ650890 hepatocellular carcinoma, cell line, Liver .d 721 to 1542 1 to 837       837/908
(92 %)
30 diff
(96.7 %id)
BQ649393 hepatocellular carcinoma, cell line, Liver .d 721 to 1555 1 to 836       836/923
(90 %)
12 diff
(98.7 %id)
DN998756 bone marrow .d 722 to 1395 10 to 682       673/682
(98 %)
8 diff
(98.9 %id)
BG338350 leiomyosarcoma cell line, uterus .d 723 to 1445 1 to 719       719/1104
(65 %)
11 diff
(99.1 %id)
BG339352 leiomyosarcoma cell line, uterus .d 723 to 1497 1 to 766       766/915
(83 %)
20 diff
(97.9 %id)
BI761517 pooled colon, kidney, stomach .d 724 to 1353 1 to 630       630/630
(100 %)
0 diff
(100 %id)
CV570634 cornea, eye .d 724 to 1341 1 to 618       618/618
(100 %)
0 diff
(100 %id)
CR996132 T-Lymphocytes .d 726 to 1020 1 to 294       294/294
(100 %)
2 diff
(99.4 %id)
CD687899 normal nasopharynx .d 728 to 1316 20 to 608       589/608
(96 %)
8 diff
(98.7 %id)
BF691221 melanotic melanoma, high MDR, skin .d 730 to 1469 1 to 740       740/740
(100 %)
23 diff
(96.9 %id)
BF691462 melanotic melanoma, high MDR, skin .d 730 to 1444 1 to 712       712/712
(100 %)
11 diff
(98.5 %id)
BG570584 lung .d 730 to 1420 1 to 686       686/686
(100 %)
8 diff
(98.9 %id)
BQ421670 large cell carcinoma, lung .d 730 to 1708 16 to 989       974/1096
(88 %)
20 diff
(98.2 %id)
BG432465 Kidney .d 731 to 1259 1 to 529       529/529
(100 %)
1 diff
(99.9 %id)
BE253601 eye, retinoblastoma .d 736 to 1520 1 to 776       776/802
(96 %)
20 diff
(97.6 %id)
BE277140 melanotic melanoma, skin .d 736 to 1170 1 to 435       435/435
(100 %)
0 diff
(100 %id)
BE389733 endometrium, adenocarcinoma cell line, uterus .d 736 to 1223 1 to 488       488/488
(100 %)
0 diff
(100 %id)
BG698571 skin .d 736 to 1363 1 to 628       628/628
(100 %)
4 diff
(99.4 %id)
BI870205 adenocarcinoma, cell line, Liver .d 736 to 1580 1 to 843       843/843
(100 %)
11 diff
(98.7 %id)
TI_57229196   .d 736 to 1580 82 to 924       843/843
(100 %)
11 diff
(98.7 %id)
BG761980 melanotic melanoma, high MDR (cell line), skin .d 737 to 1627 1 to 897       895/921
(97 %)
15 diff
(98.4 %id)
BF203297 muscle, rhabdomyosarcoma .d 738 to 1410 1 to 678       676/1157
(58 %)
11 diff
(99.1 %id)
BF308678 muscle, rhabdomyosarcoma .d 738 to 1526 1 to 777       775/851
(91 %)
10 diff
(98.9 %id)
BQ938515 epidermoid carcinoma, cell line, lung .d 739 to 1670 1 to 932       932/935
(99 %)
14 diff
(98.6 %id)
CD723863 eye, lacrimal gland .d 739 to 1349 1 to 611       611/611
(100 %)
0 diff
(100 %id)
BM804253 duodenal adenocarcinoma, cell line, small intestine .d 741 to 1504 1 to 768       768/1156
(66 %)
30 diff
(97.5 %id)
W52126 senescent fibroblast .d 742 to 898 1 to 157       157/157
(100 %)
0 diff
(100 %id)
BY796964 eye .d 746 to 1347 1 to 601       601/601
(100 %)
0 diff
(100 %id)
BG769222 melanotic melanoma, high MDR (cell line), skin .d 752 to 1440 1 to 689       689/689
(100 %)
0 diff
(100 %id)
BE408148 choriocarcinoma, placenta .d 754 to 1491 1 to 739       737/739
(99 %)
0 diff
(100 %id)
BE409002 choriocarcinoma, placenta .d 754 to 1136 1 to 383       383/385
(99 %)
1 diff
(99.8 %id)
CB146263 Liver .d 758 to 1343 1 to 586       586/586
(100 %)
0 diff
(100 %id)
BE378313 endometrium, adenocarcinoma cell line, uterus .d 760 to 1244 1 to 485       485/485
(100 %)
0 diff
(100 %id)
CD109099 brain, Pituitary .d 762 to 1627 27 to 908       882/926
(95 %)
27 diff
(97.1 %id)
BU930752 Prostate .d 763 to 1408 1 to 656       656/779
(84 %)
15 diff
(98.1 %id)
BE545340 cervical carcinoma cell line, cervix .d 781 to 1252 1 to 474       474/474
(100 %)
3 diff
(99.4 %id)
AL578243 placenta .d 790 to 1853 1060 to 1 A2X A3L S4P C5V V6X ...     1060/1060
(100 %)
7 diff
(99.4 %id)
BF027418 melanotic melanoma, skin .d 790 to 1555 11 to 772       762/997
(76 %)
28 diff
(97.2 %id)
BE747238 adenocarcinoma cell line, ovary .d 791 to 1547 1 to 754       754/977
(77 %)
8 diff
(99.2 %id)
BM716436 eye, lens .d 793 to 1202 1 to 409       409/409
(100 %)
2 diff
(99.6 %id)
BT007003   .d 796 to 1771 1 to 976       976/978
(99 %)
1 diff
(99.9 %id)
CR457010   .d 796 to 1769 1 to 974       974/978
(99 %)
1 diff
(99.9 %id)
TI_1948105580   .d 796 to 1626 124 to 954       831/1067
(77 %)
17 diff
(98.5 %id)
BE407246 choriocarcinoma, placenta .d 797 to 1430 1 to 634       634/635
(99 %)
2 diff
(99.7 %id)
BQ959902 leiomyosarcoma, uterus .d 817 to 1716 1 to 905       903/911
(99 %)
12 diff
(98.7 %id)
CN396200 embryonic stem cells, cell lines H1, H7, andH9 .d 838 to 1411 1 to 574       574/574
(100 %)
0 diff
(100 %id)
BQ646164 hepatocellular carcinoma, cell line, Liver .d 848 to 1702 1 to 857       857/858
(99 %)
5 diff
(99.5 %id)
BI759010 pooled colon, kidney, stomach .d 854 to 1669 1 to 816       816/816
(100 %)
7 diff
(99.2 %id)
TI_57145910   .d 854 to 1669 35 to 850       816/850
(96 %)
7 diff
(99.2 %id)
AA626415 lung, lung carcinoma .d 861 to 1409 1 to 547       547/548
(99 %)
5 diff
(99.1 %id)
BG748211 eye, normal pigmented retinal epithelium .d 878 to 1507 1 to 631       631/631
(100 %)
2 diff
(99.7 %id)
CN396203 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 895 to 1471 1 to 577       577/577
(100 %)
0 diff
(100 %id)
CK002202 brain/CNS, Bulk tissue from Human Spinal cord .d 949 to 1590 1 to 642       642/646
(99 %)
7 diff
(99.0 %id)
CN396197 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 970 to 1425 1 to 456       456/456
(100 %)
0 diff
(100 %id)
BF026255 melanotic melanoma, skin .d 974 to 1713 1 to 737       735/943
(77 %)
20 diff
(97.9 %id)
BE276619 melanotic melanoma, skin .d 975 to 1483 1 to 509       509/509
(100 %)
0 diff
(100 %id)
BU957576 adenocarcinoma, cell line, breast .d 980 to 1708 1 to 735   AAA   733/913
(80 %)
6 diff
(99.4 %id)
TI_149297954   .d 1003 to 1865 949 to 92   tiling clone, AAA   858/987
(86 %)
14 diff
(98.6 %id)
TI_149300676   .d 1003 to 1864 913 to 57   AAA   857/974
(87 %)
8 diff
(99.2 %id)
W24010 senescent fibroblast .d 1024 to 1425 1 to 404       404/404
(100 %)
2 diff
(99.6 %id)
TI_149311221   .d 1025 to 1864 924 to 88   AAA   837/958
(87 %)
20 diff
(98.0 %id)
AL521636 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 1060 to 1837 778 to 1   fully sequenced,   778/778
(100 %)
1 diff
(99.9 %id)
D55857   .d 1094 to 1586 1 to 493       493/493
(100 %)
0 diff
(100 %id)
AL524833 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 1121 to 1840 719 to 1   fully sequenced,   719/719
(100 %)
11 diff
(98.5 %id)
AL562553 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 1121 to 1827 709 to 6   fully sequenced,   704/709
(99 %)
15 diff
(97.9 %id)
AL527271 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 1121 to 1843 729 to 5   fully sequenced,   725/729
(99 %)
27 diff
(96.3 %id)
AL529458 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .d 1121 to 1839 717 to 1   fully sequenced,   717/717
(100 %)
11 diff
(98.5 %id)
CN396199 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 1134 to 1545 1 to 412       412/412
(100 %)
0 diff
(100 %id)
BQ778183 Pancreas, Purified pancreatic islet .d 1246 to 1863 618 to 1       618/618
(100 %)
0 diff
(100 %id)
ES314953 occipital scalp hair, skin .d 1258 to 1432 1 to 175       175/175
(100 %)
0 diff
(100 %id)
FN060894 breast carcinoma .d 1288 to 1376 1 to 89       89/89
(100 %)
0 diff
(100 %id)
BU735213 eye, lens .d 1288 to 1865 596 to 19   AAA   578/578
(100 %)
0 diff
(100 %id)
AL519411 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 1306 to 1796 527 to 38   fully sequenced,   490/527
(92 %)
1 diff
(99.9 %id)
AA485083 germinal center B cell .d 1478 to 1858 397 to 17   AAA   381/387
(98 %)
0 diff
(100 %id)
DB059552 testis .e 1 to 510 2 to 511   tiling clone, capped   510/510
(100 %)
0 diff
(100 %id)
TI_57243598   .e 22 to 856 26 to 856       827/857
(96 %)
19 diff
(97.8 %id)
AU142682   .e 22 to 773 2 to 755   capped   754/830
(90 %)
4 diff
(99.6 %id)
AU143622   .e 22 to 860 2 to 841   capped   840/843
(99 %)
7 diff
(99.2 %id)
BM781566 Ascites, stomach .e 28 to 564 1 to 537       537/537
(100 %)
0 diff
(100 %id)
BI915840 brain .e 29 to 856 1 to 824       824/825
(99 %)
13 diff
(98.5 %id)
BI754683 brain .e 32 to 811 1 to 778       778/778
(100 %)
16 diff
(98.0 %id)
TI_57217383   .e 33 to 811 36 to 812       773/812
(95 %)
21 diff
(97.5 %id)
BI088640 cervix .e 34 to 538 1 to 506       506/507
(99 %)
6 diff
(98.9 %id)
CB106246 Liver .e 35 to 449 1 to 415       415/415
(100 %)
4 diff
(99.1 %id)
BU166803 melanotic melanoma, skin .e 41 to 902 1 to 862       862/862
(100 %)
4 diff
(99.6 %id)
BE383819 brain, neuroblastoma .e 43 to 773 26 to 753       724/841
(86 %)
14 diff
(98.4 %id)
DA355335 subthalamic nucleus .e 44 to 604 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
AA213719   .e 50 to 283 1 to 234       234/321
(72 %)
9 diff
(97.2 %id)
BI195048 brain, neuroblastoma .e 52 to 620 1 to 578       578/868
(66 %)
20 diff
(97.7 %id)
BE893768 melanotic melanoma, skin .e 58 to 773 1 to 708       708/758
(93 %)
18 diff
(97.7 %id)
BF184871 bone marrow, from chronic myelogenous leukemia .e 60 to 720 1 to 657       657/674
(97 %)
21 diff
(96.9 %id)
BG614627 embryonal carcinoma, testis .e 60 to 774 1 to 723       723/784
(92 %)
25 diff
(96.9 %id)
CB114368 Liver .e 61 to 480 1 to 420       420/420
(100 %)
5 diff
(98.9 %id)
CX788871 human embryonic stem cells .e 72 to 827 1 to 755       755/755
(100 %)
1 diff
(99.9 %id)
BM451316 eye, retinoblastoma .e 77 to 1065 1 to 1001   tiling clone,   998/1032
(96 %)
20 diff
(98.1 %id)
BM807008 duodenal adenocarcinoma, cell line, small intestine .e 77 to 1055 1 to 986   tiling clone,   986/1008
(97 %)
15 diff
(98.6 %id)
BE740809 adenocarcinoma cell line, ovary .e 151 to 973 1 to 813       813/871
(93 %)
21 diff
(97.6 %id)
DA130313 alzheimer cortex .e 175 to 735 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BM786895 stomach .e 175 to 852 1 to 678       678/678
(100 %)
0 diff
(100 %id)
BF306976 muscle, rhabdomyosarcoma .e 188 to 944 1 to 755       755/967
(78 %)
18 diff
(98.2 %id)
CB214986 normal endometrium, late proliferativephase, cycle day 13, uterus .e 188 to 758 1 to 571       571/571
(100 %)
2 diff
(99.7 %id)
AI751151 Bone, Hip .e 190 to 583 9 to 402       394/402
(98 %)
0 diff
(100 %id)
BF679872 Prostate .e 192 to 970 1 to 785       785/868
(90 %)
34 diff
(96.1 %id)
DT215987 brain .e 193 to 857 1 to 665       665/665
(100 %)
1 diff
(99.9 %id)
CB145198 Liver .e 193 to 716 1 to 524       524/524
(100 %)
0 diff
(100 %id)
DA628783 Kidney .e 194 to 701 2 to 510   capped   509/509
(100 %)
2 diff
(99.7 %id)
DA685502   .e 194 to 760 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DB130459 thymus .e 194 to 722 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
BG613741 embryonal carcinoma, testis .e 203 to 969 1 to 762       762/982
(77 %)
33 diff
(96.7 %id)
BG761557 melanotic melanoma, high MDR (cell line), skin .e 205 to 836 1 to 631       631/631
(100 %)
6 diff
(99.1 %id)
FN079720 breast carcinoma .e 207 to 281 72 to 1     Submitted on the opposite strand 72/74
(97 %)
3 diff
(96.0 %id)
CN396185 embryonic stem cells, DMSO-treated H9 cellline .e 211 to 940 1 to 730       730/730
(100 %)
0 diff
(100 %id)
BU188895 melanotic melanoma, skin .e 211 to 948 1 to 747       747/860
(86 %)
16 diff
(98.2 %id)
BU178771 eye, retinoblastoma .e 211 to 971 12 to 774       763/984
(77 %)
17 diff
(98.3 %id)
BG324290 Kidney, renal cell adenocarcinoma .e 213 to 971 1 to 753       753/939
(80 %)
16 diff
(98.3 %id)
CD703762 normal nasopharynx .e 216 to 834 11 to 628       618/628
(98 %)
8 diff
(98.8 %id)
BG564319 Liver .e 222 to 971 1 to 764       764/776
(98 %)
30 diff
(96.2 %id)
CR747624 ovary (pool of 3) .e 224 to 739 1 to 516       516/516
(100 %)
0 diff
(100 %id)
BF978439 melanotic melanoma, high MDR, skin .e 224 to 955 1 to 724       724/766
(94 %)
10 diff
(98.7 %id)
BM804925 ovary (pool of 3) .e 225 to 945 1 to 729       729/1064
(68 %)
11 diff
(99.0 %id)
BE266367 lung, small cell carcinoma .e 233 to 806 1 to 576       576/576
(100 %)
3 diff
(99.5 %id)
BE274146 melanotic melanoma, skin .e 251 to 940 1 to 684       684/712
(96 %)
13 diff
(98.2 %id)
BF206879 brain, neuroblastoma .e 255 to 978 1 to 709       711/956
(74 %)
35 diff
(96.4 %id)
BG682476 skin, squamous cell carcinoma .e 264 to 869 61 to 666       606/666
(90 %)
10 diff
(98.5 %id)
BG938604 Bone, Hip .e 320 to 939 25 to 644       620/644
(96 %)
6 diff
(99.1 %id)
CD621746   .e 336 to 862 527 to 1       527/527
(100 %)
6 diff
(98.9 %id)
BF240588 bone marrow, from acute myelogenous leukemia .e 336 to 971 38 to 672   tiling clone,   635/899
(70 %)
19 diff
(97.9 %id)
CD621747   .e 347 to 792 311 to 764       454/454
(100 %)
18 diff
(96.1 %id)
CD621744   .e 353 to 862 511 to 1       509/515
(98 %)
4 diff
(99.3 %id)
CD621745   .e 353 to 862 169 to 676       508/515
(98 %)
12 diff
(97.7 %id)
CD621748   .e 353 to 862 510 to 1       510/514
(99 %)
4 diff
(99.3 %id)
CD621749   .e 353 to 862 511 to 1       511/515
(99 %)
3 diff
(99.5 %id)
CD621750   .e 353 to 862 157 to 667       511/518
(98 %)
14 diff
(97.3 %id)
CD621752   .e 353 to 884 150 to 682       533/539
(98 %)
9 diff
(98.4 %id)
AA371799 pituitary gland .e 376 to 707 1 to 331       331/331
(100 %)
1 diff
(99.7 %id)
CD621756   .e 382 to 862 481 to 1       481/521
(92 %)
3 diff
(99.5 %id)
AA074933   .e 410 to 943 27 to 562       536/562
(95 %)
70 diff
(87.6 %id)
CV424235 colon_ins .e 412 to 777 1 to 367       367/367
(100 %)
2 diff
(99.5 %id)
R94642 liver and spleen .e 412 to 476 1 to 66       66/66
(100 %)
3 diff
(95.5 %id)
AA258953 germinal center B cell .e 412 to 720 1 to 309       309/309
(100 %)
37 diff
(88.1 %id)
CV027259 mixed .e 418 to 953 1 to 536       536/536
(100 %)
1 diff
(99.9 %id)
FN175937 breast carcinoma .e 428 to 503 102 to 28     Submitted on the opposite strand 75/102
(73 %)
0 diff
(100 %id)
AW837374 leiomios .e 502 to 755 261 to 1       261/267
(97 %)
15 diff
(94.4 %id)
BE081699 breast .e 502 to 610 111 to 2     Submitted on the opposite strand 110/117
(94 %)
0 diff
(100 %id)
BQ328534 leiomios .e 502 to 771 312 to 44       269/318
(84 %)
3 diff
(99.1 %id)
BQ328536 leiomios .e 502 to 774 286 to 13       275/292
(94 %)
4 diff
(98.7 %id)
FN095027 breast carcinoma .e 509 to 594 86 to 1     Submitted on the opposite strand 86/86
(100 %)
0 diff
(100 %id)
BM834829 stomach .e 523 to 767 1 to 245       245/245
(100 %)
2 diff
(99.2 %id)
FN100584 breast carcinoma .e 535 to 630 95 to 3     Submitted on the opposite strand 93/95
(97 %)
0 diff
(100 %id)
CN396193 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 542 to 773 1 to 232       232/232
(100 %)
0 diff
(100 %id)
FN123455 breast carcinoma .e 562 to 630 1 to 69       69/82
(84 %)
6 diff
(92.7 %id)
FN072407 breast carcinoma .e 689 to 758 1 to 70       70/71
(98 %)
1 diff
(98.6 %id)
EC468000 Prostate .e 735 to 837 1 to 102       102/102
(100 %)
1 diff
(99.1 %id)
FN142833 breast carcinoma .e 738 to 835 94 to 1     Submitted on the opposite strand 94/94
(100 %)
3 diff
(96.9 %id)
BG315244   .e 762 to 939 178 to 1       178/178
(100 %)
1 diff
(99.5 %id)
EC578313 Prostate .e 808 to 912 105 to 1       105/105
(100 %)
0 diff
(100 %id)
AU160689   .e 960 to 1486 526 to 1   tiling clone,   526/555
(94 %)
7 diff
(98.8 %id)
DB384173   .e 967 to 1486 522 to 1       522/550
(94 %)
14 diff
(97.5 %id)
AA363516 Bone .e 970 to 1281 1 to 311       311/311
(100 %)
2 diff
(99.4 %id)
BQ377365 uterus .e 970 to 1261 292 to 1   tiling clone,   292/292
(100 %)
0 diff
(100 %id)
CV398607 colon_ins .e 987 to 1332 408 to 61     Submitted on the opposite strand 351/408
(86 %)
10 diff
(97.6 %id)
FN103263 breast carcinoma .e 992 to 1085 1 to 94       94/94
(100 %)
1 diff
(99.0 %id)
FN047635 breast carcinoma .e 994 to 1069 76 to 1     Submitted on the opposite strand 76/77
(98 %)
0 diff
(100 %id)
AA213720   .e 997 to 1487 491 to 1   tiling clone,   491/492
(99 %)
6 diff
(98.8 %id)
FN140405 breast carcinoma .e 1052 to 1132 1 to 84       84/85
(98 %)
5 diff
(94.2 %id)
FN145510 breast carcinoma .e 1054 to 1142 1 to 88       88/88
(100 %)
3 diff
(96.6 %id)
BQ376732 uterus .e 1072 to 1325 275 to 22       254/278
(91 %)
7 diff
(97.5 %id)
FN089688 breast carcinoma .e 1107 to 1202 96 to 1     Submitted on the opposite strand 96/96
(100 %)
1 diff
(99.0 %id)
AA809830 germinal center B cell .e 1137 to 1332 202 to 5       199/202
(98 %)
4 diff
(98.1 %id)
FN062425 breast carcinoma .e 1139 to 1231 1 to 93       93/93
(100 %)
0 diff
(100 %id)
R94643 liver and spleen .e 1165 to 1420 256 to 1       256/256
(100 %)
0 diff
(100 %id)
EC502088 Prostate .e 1192 to 1294 1 to 102       102/102
(100 %)
6 diff
(94.2 %id)
EC465648 Prostate .e 1203 to 1300 1 to 98       98/98
(100 %)
0 diff
(100 %id)
EC480288 Prostate .e 1203 to 1299 1 to 97       97/97
(100 %)
0 diff
(100 %id)
FN164257 breast carcinoma .e 1246 to 1332 91 to 6     Submitted on the opposite strand 86/94
(91 %)
0 diff
(100 %id)
BG475984 melanotic melanoma, skin .f 1 to 704 3 to 709   tiling clone,   707/709
(99 %)
10 diff
(98.6 %id)
BG477538 melanotic melanoma, skin .f 1 to 909 3 to 915   tiling clone,   915/916
(99 %)
42 diff
(95.5 %id)
BQ642484 lymph, lymphoma, cell line .f 3 to 625 12 to 637       623/992
(62 %)
19 diff
(98.1 %id)
AA216580 brain, neuroepithelial cells .f 252 to 789 1 to 543   tiling clone,   543/543
(100 %)
14 diff
(97.5 %id)
AA218541 brain, neuroepithelial cells .f 252 to 690 1 to 454       454/459
(98 %)
25 diff
(94.6 %id)
AA227051 brain, neuroepithelial cells .f 252 to 560 1 to 309       309/309
(100 %)
6 diff
(98.1 %id)
AA226943 brain, neuroepithelial cells .f 812 to 1287 490 to 19   tiling clone, AAA   472/472
(100 %)
6 diff
(98.8 %id)
AA218542 brain, neuroepithelial cells .f 835 to 1287 470 to 19   tiling clone, AAA   452/452
(100 %)
6 diff
(98.7 %id)
AA216590 brain, neuroepithelial cells .f 921 to 1280 385 to 25   AAA   361/374
(96 %)
3 diff
(99.2 %id)
CB051967 leiomyosarcoma, soft tissue .g 1 to 512 10 to 521   tiling clone,   512/521
(98 %)
7 diff
(98.7 %id)
CN396192 embryonic stem cells, cell lines H1, H7, andH9 .g 41 to 724 1 to 684   tiling clone,   684/684
(100 %)
2 diff
(99.8 %id)
CR593548 neuroblastoma .g 600 to 1152 1 to 553       553/553
(100 %)
0 diff
(100 %id)
CR593332 neuroblastoma .g 601 to 1155 1 to 555   tiling clone,   555/555
(100 %)
0 diff
(100 %id)
BX411949 neuroblastoma .g 601 to 1141 554 to 12       543/554
(98 %)
0 diff
(100 %id)
BX423931 neuroblastoma .g 601 to 1155 1 to 555       555/555
(100 %)
5 diff
(99.1 %id)
BX437879 neuroblastoma .g 601 to 1155 1 to 555       555/555
(100 %)
7 diff
(98.8 %id)
AA996021 2 pooled tumors (clear cell type), Kidney .g 831 to 1155 327 to 1       327/327
(100 %)
19 diff
(94.2 %id)
BX416422 neuroblastoma .g 840 to 1152 1 to 313       313/313
(100 %)
1 diff
(99.7 %id)
BP196113 adrenal gland .h 1 to 579 1 to 582   tiling clone,   582/582
(100 %)
4 diff
(99.4 %id)
CV366020 nervous_normal .h 543 to 885 373 to 31   tiling clone, Submitted on the opposite strand 343/373
(91 %)
1 diff
(99.8 %id)
CV366056 nervous_normal .h 543 to 885 373 to 31     Submitted on the opposite strand 343/373
(91 %)
1 diff
(99.8 %id)
CV366060 nervous_normal .h 543 to 885 373 to 31     Submitted on the opposite strand 343/373
(91 %)
1 diff
(99.8 %id)
BI044126 ovary .h 810 to 1422 613 to 8   tiling clone,   606/631
(96 %)
7 diff
(98.9 %id)
DW431638 Liver .h 878 to 1136 10 to 268   tiling clone,   259/268
(96 %)
6 diff
(97.8 %id)
BI043423 ovary .h 1027 to 1422 422 to 23   tiling clone,   400/450
(88 %)
15 diff
(96.7 %id)
BJ996670 hepatoblastoma .i 1 to 549 1 to 549   tiling clone,   549/549
(100 %)
1 diff
(99.9 %id)
BE734956 choriocarcinoma, placenta .i 40 to 849 33 to 841   tiling clone,   809/887
(91 %)
37 diff
(95.9 %id)
BJ996671 hepatoblastoma .i 672 to 1051 380 to 1   tiling clone,   380/380
(100 %)
0 diff
(100 %id)
CN396195 embryonic stem cells, cell lines H1, H7, andH9 .j 1 to 712 13 to 725 exact tiling clone,   713/725
(98 %)
6 diff
(99.2 %id)
BI758074 brain .k 1 to 855 1 to 861   tiling clone,   861/900
(95 %)
14 diff
(98.5 %id)
TI_57239727   .k 40 to 855 30 to 841       812/852
(95 %)
9 diff
(99.0 %id)
CN396196 embryonic stem cells, cell lines H1, H7, andH9 .k 62 to 731 1 to 668       668/668
(100 %)
4 diff
(99.5 %id)
BQ269012 Pancreas, Purified pancreatic islet .k 70 to 649 1 to 580       580/580
(100 %)
3 diff
(99.5 %id)
CN396198 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .k 76 to 665 1 to 590       590/590
(100 %)
3 diff
(99.5 %id)
BG105341 adrenal cortex carcinoma, cell line, adrenal gland .k 246 to 1012 1 to 764 S177P V178C R179V P180S A181C ... AAA   764/886
(86 %)
22 diff
(97.6 %id)
R72732 breast .k 302 to 473 1 to 172       172/172
(100 %)
1 diff
(99.5 %id)
BQ948897 sciatic nerve .k 335 to 1172 1 to 835   tiling clone,   835/1041
(80 %)
15 diff
(98.6 %id)
BF568733 epithelioid carcinoma cell line, Pancreas .k 582 to 1172 1 to 591   fully sequenced,   591/591
(100 %)
1 diff
(99.9 %id)
BU684580 lung, Primary Lung Cystic Fibrosis EpithelialCells .k 596 to 1170 593 to 19   AAA   575/575
(100 %)
2 diff
(99.7 %id)
BE832597 marrow .k 716 to 1132 418 to 1       418/418
(100 %)
15 diff
(96.5 %id)
DB566553 hypothalamus .k 721 to 1171 1 to 451     Submitted on the opposite strand 451/451
(100 %)
1 diff
(99.8 %id)
AI563934 anaplastic oligodendroglioma, brain .k 722 to 1172 457 to 7       451/457
(98 %)
1 diff
(99.8 %id)
AI378911 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .k 745 to 1174 437 to 8   tiling clone,   430/437
(98 %)
0 diff
(100 %id)
BF569032 epithelioid carcinoma cell line, Pancreas .k 748 to 1128 385 to 3   fully sequenced,   383/385
(99 %)
1 diff
(99.8 %id)
AI032017 parathyroid gland, parathyroid tumor .k 749 to 1170 428 to 7       422/428
(98 %)
0 diff
(100 %id)
BQ354926 head_neck .k 753 to 1082 330 to 1       330/330
(100 %)
11 diff
(96.7 %id)
AA769351 germinal center B cell .k 792 to 1173 414 to 33   AAA   382/382
(100 %)
0 diff
(100 %id)
AA593080 colon, colon tumor RER+ .k 803 to 1170 367 to 1       367/367
(100 %)
2 diff
(99.5 %id)
AA129588 uterus .k 849 to 1170 360 to 37   AAA   324/375
(86 %)
5 diff
(98.7 %id)
AA889482 parathyroid gland, parathyroid tumor .k 852 to 1174 327 to 3       325/333
(97 %)
7 diff
(97.9 %id)
BG222833 brain, glioblastoma without EGFR amplification .k 852 to 1171 339 to 20   AAA   320/338
(94 %)
5 diff
(98.6 %id)
AA862989 Kidney .k 856 to 1171 324 to 11   AAA   314/314
(100 %)
2 diff
(99.4 %id)
BU588987 mixed (pool of 40 RNAs) .k 858 to 1168 1 to 311       311/348
(89 %)
4 diff
(98.9 %id)
AA506087 breast .k 859 to 1168 315 to 1       315/319
(98 %)
18 diff
(94.4 %id)
N30891.
matches multiple genes
placenta .k 860 to 1172 316 to 3     also hits gene ATXN1LandKIAA0174 314/316
(99 %)
1 diff
(99.7 %id)
T16712   .k 861 to 1171 311 to 1       311/311
(100 %)
0 diff
(100 %id)
AI000171 breast .k 867 to 1170 303 to 1       303/308
(98 %)
19 diff
(93.9 %id)
C20972   .k 875 to 1172 1 to 301       301/327
(92 %)
4 diff
(98.8 %id)
N63213 cochlea, ear .k 879 to 1171 315 to 22   AAA   294/294
(100 %)
1 diff
(99.7 %id)
AI751326 Bone, Hip .k 879 to 1137 268 to 9       260/268
(97 %)
1 diff
(99.7 %id)
AI742754 pooled .k 880 to 1172 299 to 7       293/299
(97 %)
1 diff
(99.7 %id)
R72654 breast .k 884 to 1150 267 to 1       267/267
(100 %)
1 diff
(99.7 %id)
AI193134 lung .k 886 to 1168 283 to 1       283/283
(100 %)
3 diff
(99.0 %id)
AI872734 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .k 889 to 1171 294 to 11   AAA   284/292
(97 %)
5 diff
(98.3 %id)
AA100315   .k 892 to 1170 12 to 291       280/293
(95 %)
11 diff
(96.3 %id)
AA627402 colon, colon tumor RER+ .k 905 to 1170 265 to 1       265/265
(100 %)
2 diff
(99.3 %id)
N88026   .k 912 to 1170 1 to 257   AAA   257/257
(100 %)
4 diff
(98.5 %id)
T27586 Pancreas .k 968 to 1172 218 to 13     Submitted on the opposite strand 206/218
(94 %)
2 diff
(99.1 %id)
AA862394 Kidney .k 975 to 1171 207 to 12   AAA   196/196
(100 %)
1 diff
(99.5 %id)
BQ057215 lymph, lymphoma, cell line .l 1 to 845 1 to 854   tiling clone,   854/1014
(84 %)
39 diff
(96.2 %id)
AW733021 Burkitt lymphoma, lymph .l 55 to 568 1 to 515   tiling clone,   515/515
(100 %)
0 diff
(100 %id)
BX359742 Placenta Cot 25-normalized .l 203 to 1083 1 to 885 L10H S11* tiling clone,   885/885
(100 %)
5 diff
(99.5 %id)
BG468896 adenocarcinoma cell line, colon .l 214 to 838 1 to 641       639/675
(94 %)
22 diff
(96.8 %id)
AA227045 brain, neuroepithelial cells .l 247 to 555 1 to 310       310/310
(100 %)
3 diff
(99.1 %id)
TI_154110379   .l 289 to 1082 851 to 62   tiling clone, AAA   790/938
(84 %)
7 diff
(99.3 %id)
AA773003   .l 297 to 948 653 to 1       653/653
(100 %)
56 diff
(91.5 %id)
TI_149298137   .l 300 to 1081 870 to 86   AAA   785/966
(81 %)
24 diff
(97.6 %id)
CA448035 Chondrosarcoma, Left Pubic Bone .l 384 to 1082 717 to 19   AAA   699/699
(100 %)
0 diff
(100 %id)
BG256770 embryonal carcinoma, cell line, testis .l 407 to 1082 1 to 676   AAA   676/676
(100 %)
18 diff
(97.4 %id)
CN396186 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .l 577 to 1074 1 to 498       498/498
(100 %)
1 diff
(99.8 %id)
DB570067 hypothalamus .l 582 to 1082 1 to 501     Submitted on the opposite strand 501/501
(100 %)
0 diff
(100 %id)
DB568082 hypothalamus .l 603 to 1082 1 to 480     Submitted on the opposite strand 480/480
(100 %)
0 diff
(100 %id)
CA308419 Alveolar Macrophage, lung .l 616 to 1082 484 to 19   AAA   466/466
(100 %)
3 diff
(99.4 %id)
AA831679 germinal center B cell .l 620 to 1047 425 to 1       425/425
(100 %)
3 diff
(99.3 %id)
BI668309 brain, hypothalamus .m 1 to 857 1 to 869   tiling clone,   869/961
(90 %)
23 diff
(97.7 %id)
TI_44346276   .m 6 to 857 127 to 990       864/1082
(79 %)
25 diff
(97.7 %id)
AK307237 Liver .m 40 to 878 1 to 839       839/839
(100 %)
2 diff
(99.8 %id)
CN396190 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .m 61 to 735 1 to 673       673/673
(100 %)
3 diff
(99.6 %id)
DB258129 uterus .m 241 to 828 2 to 589   capped   588/588
(100 %)
5 diff
(99.2 %id)
DA373890 thalamus .m 244 to 805 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA430032 colon .m 246 to 816 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA917724 small intestine .m 246 to 807 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA927467 small intestine .m 246 to 814 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DB104384 thymus .m 246 to 790 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DB247914 uterus .m 246 to 763 2 to 519   capped   518/518
(100 %)
0 diff
(100 %id)
BX387644 Placenta Cot 25-normalized .m 248 to 1253 1 to 997   tiling clone,   997/1007
(99 %)
16 diff
(98.5 %id)
BQ422565 embryonal carcinoma, cell line, testis .m 260 to 1104 1 to 847       847/851
(99 %)
7 diff
(99.2 %id)
DA966157 stomach .m 278 to 833 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA930279 small intestine .m 281 to 860 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
BI014469 lung_tumor .m 660 to 1113 454 to 4       451/454
(99 %)
0 diff
(100 %id)
DW428761 Liver .m 962 to 1219 17 to 274       258/274
(94 %)
10 diff
(96.4 %id)
AI110770 Liver .m 1009 to 1503 522 to 28   AAA   495/607
(81 %)
6 diff
(99.1 %id)
AF074677 Liver .m 1009 to 1503 522 to 28   tiling clone, AAA   495/607
(81 %)
6 diff
(99.1 %id)
AA574110 breast .m 1104 to 1505 401 to 1       401/401
(100 %)
10 diff
(97.6 %id)
AI287528 placenta .m 1125 to 1506 382 to 1   tiling clone,   382/382
(100 %)
0 diff
(100 %id)
BQ268741 Pancreas, Purified pancreatic islet .m 1131 to 1509 379 to 1       379/379
(100 %)
3 diff
(99.3 %id)
BX387643 Placenta Cot 25-normalized .m 1288 to 2359 1062 to 1 H53N tiling clone,   1062/1105
(96 %)
21 diff
(98.1 %id)
BX447496 placenta .m 1478 to 2336 857 to 1 E2R A3X L4W V5X A6L ...     857/857
(100 %)
22 diff
(97.5 %id)
BX412226 placenta .m 1500 to 2368 872 to 1 exact tiling clone,   872/873
(99 %)
5 diff
(99.5 %id)
AV751120 Pituitary .m 1514 to 1856 1 to 339       339/410
(82 %)
10 diff
(97.6 %id)
AA340098 epithelium, skin .m 1519 to 1824 1 to 306       306/306
(100 %)
0 diff
(100 %id)
AK311175 brain .n 1 to 1558 1 to 1559   tiling clone,   1559/1559
(100 %)
19 diff
(98.8 %id)
DC319357 brain .n 1 to 591 1 to 591       591/591
(100 %)
1 diff
(99.9 %id)
BC033287 Skin, squamous cell carcinoma .n 1024 to 1970 1 to 947 exact tiling clone, available from MGC, AAA   947/947
(100 %)
6 diff
(99.4 %id)
BG679833 skin, squamous cell carcinoma .n 1024 to 1732 1 to 742   available from MGC,   742/811
(91 %)
15 diff
(98.2 %id)
CN396202 embryonic stem cells, DMSO-treated H9 cellline .n 1060 to 1689 1 to 631       631/631
(100 %)
6 diff
(99.1 %id)
AI469018 follicular lymphoma, lymph node .n 1351 to 1925 1 to 574 R118G D119M A120X H122I P123L ...   Submitted on the opposite strand 574/574
(100 %)
5 diff
(99.2 %id)
BE780959 eye, retinoblastoma .o-u 1 to 372 1 to 371 H18P F19S M20W V21* tiling clone,   371/371
(100 %)
1 diff
(99.8 %id)
CR975058 T-Lymphocytes .p 1 to 872 1 to 870 exact tiling clone,   870/873
(99 %)
7 diff
(99.2 %id)
CV571424 cornea, eye .p 21 to 627 1 to 607 exact     607/607
(100 %)
1 diff
(99.9 %id)
CN396204 embryonic stem cells, DMSO-treated H9 cellline .p 25 to 666 1 to 642 exact     642/642
(100 %)
1 diff
(99.9 %id)
CK825633 Pancreas, Purified pancreatic islet .p 67 to 628 1 to 562 exact   Submitted on the opposite strand 562/562
(100 %)
1 diff
(99.9 %id)
BE514214 Burkitt lymphoma, lymph .q 1 to 696 28 to 724 exact tiling clone,   697/823
(84 %)
12 diff
(98.6 %id)
AA299440 uterus .r 1 to 266 1 to 268 M14X D55* tiling clone,   268/268
(100 %)
3 diff
(98.9 %id)
AK307288 Prostate .s 1 to 955 1 to 955 L32S T63A tiling clone,   955/955
(100 %)
4 diff
(99.6 %id)
DA875979 Prostate .s 2 to 555 2 to 557 L32S T63A capped   556/563
(98 %)
5 diff
(99.2 %id)
BM794951 Ascites, stomach .t-u 1 to 675 1 to 675 exact tiling clone,   675/675
(100 %)
0 diff
(100 %id)
CB242230 Human Lung Epithelial cells, lung .t-u 57 to 696 658 to 19 exact tiling clone, AAA   640/653
(98 %)
0 diff
(100 %id)
BG230714 blood, lymphocyte .t-u 134 to 696 563 to 1 exact     563/563
(100 %)
0 diff
(100 %id)
AI277909 placenta .t-u 199 to 696 502 to 5 exact     498/502
(99 %)
0 diff
(100 %id)
AI269884 Kidney .t-u 337 to 696 366 to 7       360/366
(98 %)
0 diff
(100 %id)
AA643349 epithelium (cell line), Prostate .u 1 to 335 335 to 1 exact tiling clone,   335/335
(100 %)
0 diff
(100 %id)
AA723218 heart .u 27 to 338 311 to 1 exact tiling clone,   311/311
(100 %)
1 diff
(99.7 %id)
117 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o-u, .p, .q, .r, .s, .t-u, .u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI